Walgreens is set to close five locations across Los Angeles and Orange counties in the coming weeks — a move that could result in at least 93 job losses as the struggling retailer moves ahead with a downsizing that will see around 1,200 closures nationwide.The pharmacy chain will shutter stores in Whittier, downtown Los Angeles, Orange, Placentia and Stanton, according to a notice submitted to California’s Employment Development Department.The store closures will lead to layoffs for a range of employees, in ...

Walgreens Boots Alliance (WBA -6.12%) faces an uncertain path ahead. Its financials haven't been strong in recent years, and its struggling pharmaceutical operations face growing competition. While it is slashing its store count, there's no surefire strategy that will turn the business around.Shares of the pharmacy retailer haven't been this low in decades. And while some investors may have been willing to just hang on to the stock amid the uncertainty and simply collect its dividend, now, even that is gone ...

I last analyzed Walgreens Boots Alliance (NASDAQ: WBA ) on 10-29-2024. In an article entitled "Walgreens Q4: 2 Signs Of A Dividend Trap," I rated the stock as a sell and cautioned readers of As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy ...

SAN DIEGO, Feb. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"), have until March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens as well as ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from April 2, 2020, to January 16, 2025 [1] Allegations - The complaint alleges that Walgreens violated federal laws related to the dispensation of prescription medication and reimbursement, despite claiming a commitment to regulatory compliance [1] - It is claimed that the company's conduct would lead to increased regulatory scrutiny, civil liability, and reputational damage [1] - The revenues from prescription medication sales are said to be unsustainable due to their reliance on unlawful practices [1] - As a result, Walgreens' public statements during the class period are characterized as materially false and misleading [1] Next Steps for Shareholders - Shareholders who purchased WBA shares during the specified timeframe are encouraged to register for the class action by March 31, 2025, to potentially become lead plaintiffs [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2] About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3]

Group 1: Stock Performance - Walgreens Boots Alliance (WBA) stock closed at $10.12, reflecting a +0.7% change from the previous trading day's closing, outperforming the S&P 500's daily loss of 0.95% [1] - The stock has increased by 9% over the past month, surpassing the Retail-Wholesale sector's gain of 7.69% and the S&P 500's gain of 1.86% [1] Group 2: Earnings Forecast - The upcoming earnings report is expected to show an EPS of $0.53, indicating a 55.83% decrease from the same quarter last year [2] - The Zacks Consensus Estimate for revenue is projected at $38.07 billion, which is a 2.75% increase from the previous year [2] Group 3: Annual Estimates - For the annual period, earnings are anticipated to be $1.60 per share, reflecting a -44.44% change from last year, while revenue is expected to be $151.57 billion, indicating a +2.65% change [3] Group 4: Analyst Estimates - Recent adjustments to analyst estimates for Walgreens Boots Alliance are important as they reflect changes in short-term business dynamics, with positive revisions indicating analysts' confidence in the company's performance [4] Group 5: Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown a strong track record, with stocks rated 1 producing an average annual return of +25% since 1988 [6] - Walgreens Boots Alliance currently holds a Zacks Rank of 3 (Hold), with a 5.59% rise in the Zacks Consensus EPS estimate over the past month [6] Group 6: Valuation Metrics - Walgreens Boots Alliance has a Forward P/E ratio of 6.28, which is higher than the industry average of 4.72, indicating it is trading at a premium [7] - The company has a PEG ratio of 1.26, compared to the industry average PEG ratio of 0.72, suggesting a higher expected earnings growth rate relative to its peers [8] Group 7: Industry Ranking - The Retail - Pharmacies and Drug Stores industry, part of the Retail-Wholesale sector, holds a Zacks Industry Rank of 87, placing it in the top 35% of over 250 industries [8] - The strength of individual industry groups is measured by the Zacks Industry Rank, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [9]

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots-al ...

Core Viewpoint - A class action lawsuit has been filed against Walgreens Boots Alliance, Inc. for failing to disclose significant regulatory compliance issues during the Class Period from April 2, 2020, to January 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that Walgreens engaged in widespread violations of federal law regarding prescription medication dispensation and reimbursement [5]. - It claims that Walgreens' public statements were materially false and misleading, leading to investor damages when the truth was revealed [5]. - The lawsuit indicates that Walgreens' revenues from prescription sales were unsustainable due to unlawful conduct [5]. Group 2: Participation Information - Investors who purchased Walgreens common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly [3][6]. - A lead plaintiff must be appointed by March 31, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from April 2, 2020, to January 16, 2025 [1] Group 1: Allegations Against Walgreens - The complaint alleges that Walgreens continued to engage in widespread violations of federal law related to the dispensation of prescription medication despite claiming a commitment to improved regulatory compliance [1] - It is claimed that the conduct of Walgreens would lead to increased regulatory scrutiny, civil liability, and reputational harm when revealed [1] - The lawsuit asserts that Walgreens' revenues from prescription medication sales were unsustainable due to their unlawful conduct, making the company's public statements materially false and misleading [1] Group 2: Class Action Details - Shareholders who purchased shares of Walgreens during the specified class period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2] - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's status [2] - There is no cost or obligation for shareholders to participate in the case [2] Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]

The latest trading session saw Walgreens Boots Alliance (WBA) ending at $9.89, denoting a +1.33% adjustment from its last day's close. This change outpaced the S&P 500's 0.72% gain on the day. Elsewhere, the Dow gained 0.3%, while the tech-heavy Nasdaq added 1.35%.Coming into today, shares of the largest U.S. drugstore chain had gained 3.06% in the past month. In that same time, the Retail-Wholesale sector gained 6.17%, while the S&P 500 gained 1.02%.Market participants will be closely following the financi ...